{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:05:56Z","timestamp":1784696756276,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025-25467533"],"award-info":[{"award-number":["RS-2025-25467533"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The early detection of metabolic dysfunction-associated steatotic liver disease (MASLD) is essential. This study aims to evaluate the diagnostic utility and optimal cutoffs of alanine aminotransferase (ALT) and its derived markers, including the ALT\/aspartate aminotransferase (AST) and ALT\/high-density lipoprotein cholesterol (HDL) ratios, for predicting pediatric MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from 1,158 adolescents in the National Health and Nutritional Examination Survey (NHANES) and 263 adolescents from a real-world clinical cohort. MASLD was assessed using vibration-controlled transient elastography in the NHANES cohort and abdominal ultrasonography in the clinical cohort. Logistic regression and receiver operating characteristic (ROC) curve analyses were conducted to evaluate associations and predictive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ALT, ALT\/AST, and ALT\/HDL were significantly associated with MASLD in both datasets, even after adjusting for age and sex (all p &amp;lt; 0.001). In the NHANES cohort, the areas under the ROC curves (AUCs) for ALT, ALT\/AST, and ALT\/HDL were 0.73, 0.77, and 0.76, respectively, with optimal cutoff values of &amp;gt;14.50 for ALT, &amp;gt;0.74 for ALT\/AST, and &amp;gt;0.29 for ALT\/HDL in the total population. In the real-world clinical cohort, the corresponding AUCs were 0.84, 0.84, and 0.86, respectively. ALT\/HDL demonstrated the highest AUC in both datasets, reaching 0.92 in females in the clinical cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ALT and ALT-derived markers are valuable for predicting pediatric MASLD. Among them, the ALT\/HDL ratio demonstrated the best predictive performance, indicating that composite indices integrating markers of hepatic injury and metabolic status may enhance early detection of MASLD in children and adolescents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1808797","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:46:08Z","timestamp":1784695568000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal cutoff values of alanine aminotransferase and its derived markers for pediatric MASLD"],"prefix":"10.3389","volume":"17","author":[{"given":"Joon Young","family":"Kim","sequence":"first","affiliation":[{"name":"Gangnam Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Unit, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Unit, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Youn","sequence":"additional","affiliation":[{"name":"Gangnam Severance Hospital, Health Promotion Center, Healthcare Research Team, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jung","family":"Baik","sequence":"additional","affiliation":[{"name":"Gangnam Severance Hospital, Health Promotion Center, Healthcare Research Team, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joo","family":"Shin","sequence":"additional","affiliation":[{"name":"Yongin Severance Hospital, Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Department of Radiology, Yonsei University College of Medicine","place":["Yongin-si, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Kwon","sequence":"additional","affiliation":[{"name":"Yongin Severance Hospital, Department of Family Medicine, Yonsei University College of Medicine","place":["Yongin-si, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Byoul","family":"Lee","sequence":"additional","affiliation":[{"name":"Yongin Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine","place":["Yongin-si, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Wook","family":"Chae","sequence":"additional","affiliation":[{"name":"Gangnam Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungchul","family":"Song","sequence":"additional","affiliation":[{"name":"Gangnam Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2294046","article-title":"The pathophysiology of MASLD: an immunometabolic perspective","volume":"20","author":"Schw\u00e4rzler","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and Malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17930","article-title":"Pathogenesis of MASLD and MASH\u2013role of insulin resistance and lipotoxicity","volume":"59","author":"Bansal","year":"2024","journal-title":"Alimentary Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/diabetology6040023","article-title":"Metabolic-associated steatotic liver disease (MASLD) and type 2 diabetes: mechanisms, diagnostic approaches, and therapeutic interventions","volume":"6","author":"Ntikoudi","year":"2025","journal-title":"Diabetology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, metALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.70003","article-title":"Recent prevalence and trends of obesity and metabolic dysfunction\u2010associated steatotic liver disease (MASLD) among US adolescents: 1999 to 2020","volume":"20","author":"Sun","year":"2025","journal-title":"Pediatr Obes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction\u2013associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14744\/zkmj.2024.67209","article-title":"Predictors of pediatric non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents: is serum ALT level sufficient in detecting NAFLD","volume":"55","author":"\u00d6zer","year":"2024","journal-title":"Zeynep Kamil Med J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/mpg.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v13.i11.1688","article-title":"Abnormal liver enzymes: a review for clinicians","volume":"13","author":"Kalas","year":"2021","journal-title":"World J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY Study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-019-03362-3","article-title":"Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease","volume":"178","author":"Draijer","year":"2019","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.071","article-title":"Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels","volume":"164","author":"Molleston","year":"2014","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.06.011","article-title":"Optimal cutoffs of fatty liver index and hepatic steatosis index in diagnosing pediatric metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Song","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1071350","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease","volume":"13","author":"Ting","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2024.01.022","article-title":"ALT poorly predicts nonalcoholic fatty liver disease (NAFLD) and liver fibrosis as determined by vibration-controlled transient elastography in adult National Health and Nutrition Examination Survey 2017-2018","volume":"367","author":"Condon","year":"2024","journal-title":"Am J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12887-018-1202-z","article-title":"Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010\u20132015","volume":"18","author":"Kang","year":"2018","journal-title":"BMC Pediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.8951","article-title":"Alanine aminotransferase-old biomarker and new concept: a review","volume":"11","author":"Liu","year":"2014","journal-title":"Int J Med Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000469304","article-title":"Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients","volume":"36","author":"Nanji","year":"2017","journal-title":"Enzyme"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1239398","article-title":"The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease","volume":"14","author":"Qiu","year":"2023","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1457598","article-title":"Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States","volume":"15","author":"Xuan","year":"2024","journal-title":"Front Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.03.034","article-title":"Development and validation of the Framingham steatosis index to identify persons with hepatic steatosis","volume":"14","author":"Long","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2026.120905","article-title":"Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: a retrospective comparison across healthy, MASLD, and biopsy-staged groups","volume":"586","author":"Bithi","year":"2026","journal-title":"Clin Chim Acta"},{"key":"B27","unstructured":"National Center for Health Statistics. Clinical growth charts: Centers for Disease Control and Prevention\n          \n          \n          \n          2000"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2018.61.5.135","article-title":"The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects","volume":"61","author":"Kim","year":"2018","journal-title":"Korean J Pediatr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2346090.045","article-title":"Waist-height ratio and body mass index as indicators of obesity and cardiometabolic risk in Korean children and adolescents","volume":"29","author":"Kim","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.7570\/jomes22033","article-title":"Reference values for waist circumference and waist\u2013height ratio in Korean children and adolescents","volume":"31","author":"Lee","year":"2022","journal-title":"J Obes Metab Syndrome"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.048","article-title":"Prevalence of liver steatosis and fibrosis detected by transient elastography in adolescents in the 2017\u20132018 National Health and Nutrition Examination Survey","volume":"19","author":"Ciardullo","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10574-1","article-title":"Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort","volume":"17","author":"Zeng","year":"2023","journal-title":"Hepatol Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2022.113","article-title":"Risk of metabolic syndrome and fatty liver diseases in gastric cancer survivors: a propensity score-matched analysis","volume":"81","author":"Han","year":"2023","journal-title":"Korean J Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/met.2012.0169","article-title":"Ultrasound evaluation and correlates of fatty liver disease: a population study in a Mediterranean area","volume":"11","author":"Chiloiro","year":"2013","journal-title":"Metab Syndrome Related Disord"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001150","article-title":"AASLD practice statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children","author":"Xanthakos","year":"2025","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-024-01475-z","article-title":"Prediction of insulin resistance and elevated liver transaminases using serum uric acid and derived markers in children and adolescents","volume":"78","author":"Choi","year":"2024","journal-title":"Eur J Clin Nutr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2008.00406.x","article-title":"The triglyceride\/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors","volume":"9","author":"Quijada","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Digestive Liver Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1808797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:46:12Z","timestamp":1784695572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1808797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":42,"alternative-id":["10.3389\/fendo.2026.1808797"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1808797","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1808797"}}